Company / Operating Margin
Jazz Pharmaceuticals Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-10.1%
FY2025
5-year range
-10.1% / 24.6%
FY2021-FY2025
Trend
-157.2%
vs FY2024
Sector context
#59 of 135
Health Care
What the data says
At -10.1%, Jazz Pharmaceuticals's operating margin ranks #59 of 135 in the Health Care sector. Operating Margin has fluctuated over the past 10 years, ranging from -10.1% in FY2025 to 140.6% in FY2017.
Based on SEC 10-K filings.
-10.1% in FY2025 with a 5-year CAGR of -42.6%.
Declined from 15.1% to -10.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -26.1pp
- 5-Year Change
- -42.6pp
- 10-Year Change
- -
Sector benchmark
#59 of 135 in Health CareTop 44% of 135This company -10.1% Sector average -774.4%
▼
+98.7% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 157.2% year-over-year.
- Currently 764.4pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.1% | -157.2% |
| FY2024 | 17.6% | +16.7% |
| FY2023 | 15.1% | -5.7% |
| FY2022 | 16.0% | -35.0% |
| FY2021 | 24.6% | -24.3% |
| FY2020 | 32.5% | -0.5% |
| FY2019 | 32.7% | -17.8% |
| FY2018 | 39.8% | -71.7% |
| FY2017 | 140.6% | +743.1% |
| FY2016 | 16.7% | -56.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026